The Coalition for Epidemic Preparedness Innovations
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Global health funders fast-track three Ebola vaccines as outbreak continues to spread in Africa
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread. The Coalition for Epidemic Preparedness Innovations (CEPI) will “urgently accelerate” the development of three investigational vaccines targeting the Bundibugyo virus, responsible for the current Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, the organisation announced on Monday. "With Bundibugyo virus...
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
The global health organization Coalition for Epidemic Preparedness Innovations (CEPI) announced Monday that it will "urgently accelerate development" of three vaccine candidates against Bundibugyo ebolavirus (BDBV), pledging a little over $60 million in the effort to extinguish an outbreak currently raging out of control in the Democratic Republic of the Congo. Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical testing...
'A disease anywhere can be a disease everywhere tomorrow morning': Public health expert on Ebola and the threat of future outbreaks
'A disease anywhere can be a disease everywhere tomorrow morning': Public health expert on Ebola and the threat of future outbreaks Live Science spoke with Dr. Ali S. Khan, an epidemiologist and former assistant surgeon general of the U.S. Public Health Service, about the ongoing Ebola epidemic and the U.S.'s preparedness for future outbreaks. A deadly Ebola disease epidemic is rapidly unfolding in the Democratic Republic of the Congo (DRC) and Uganda. In May, the World Health Organization...
3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready?
3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready? The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that. The Ebola outbreak in Central Africa was declared a public health emergency of international concern in May, and since then, over 900 suspected cases and 200 deaths have been reported in the Democratic Republic of the Congo...
Survivors tell what it’s like to battle Ebola: ‘Coming out alive is an indescribable joy’
Survivors tell what it’s like to battle Ebola: ‘Coming out alive is an indescribable joy’ One nurse started feeling dizzy while he checked on patients. The vomiting started just minutes later - Bookmark - CommentsGo to comments Survivors have recounted their experiences of battling the Bundibugyo strain of the Ebola virus – a strain for which no approved medicine or vaccine currently exists. Congo is grappling with an outbreak of the virus, with at least 282 confirmed cases reported.
WHO drastically revises Ebola case count in Congo down to 116 from over 1000
The WHO confirmed 116 suspected Ebola cases in Congo, a sharp cut from previous estimates. The Ebola outbreak that is ravaging Congo may be smaller than previously thought. As of 31 May, there are 116 suspected and 321 confirmed Ebola cases in the ongoing Democratic Republic of Congo (DRC) outbreak, down from the previous estimates of over 1,000, the World Health Organization (WHO) confirmed on Tuesday.
What are the Ebola vaccines under research, and when will they be ready?
What are the Ebola vaccines under research, and when will they be ready? Research for new Ebola vaccines will be fast-tracked as experts warn the disease is moving faster than the response. East Africa is currently in the throes of a rapidly spreading Ebola epidemic, with governments scrambling to contain the virus and hundreds of people confirmed with the infection.
Race to develop Ebola vaccine as deadly strain of virus spreads
Race to develop Ebola vaccine heats up amid deadly outbreak in DRC Tue 2 Jun 2026 at 7:58am In short: Efforts have ramped up to develop a vaccine for the rare strain of Ebola amid a deadly outbreak in the Democratic Republic of Congo. More than 1,100 people are infected with the strain in the DRC and Uganda, though the true extent of the virus's spread is feared to be much wider. The WHO estimated it would take seven to nine months before the new vaccine will be ready to be tested on humans.